Schedule 13D ownership disclosure
Keros Therapeutics Inc
Security class unavailable · CUSIP: 492327101
Event date: 2020-04-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 23.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-20-117128
- Form type
- SC 13D
- Filer
- Keros Therapeutics, Inc.
- CIK
- CIK 1664710
- Filed
- Apr 23, 2020
- Reporting period
- Apr 13, 2020
- Description
- Schedule 13D beneficial ownership